These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

757 related articles for article (PubMed ID: 28551354)

  • 1. Targeting Free Radicals in Oxidative Stress-Related Human Diseases.
    Poprac P; Jomova K; Simunkova M; Kollar V; Rhodes CJ; Valko M
    Trends Pharmacol Sci; 2017 Jul; 38(7):592-607. PubMed ID: 28551354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free radicals, metals and antioxidants in oxidative stress-induced cancer.
    Valko M; Rhodes CJ; Moncol J; Izakovic M; Mazur M
    Chem Biol Interact; 2006 Mar; 160(1):1-40. PubMed ID: 16430879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in metal-induced oxidative stress and human disease.
    Jomova K; Valko M
    Toxicology; 2011 May; 283(2-3):65-87. PubMed ID: 21414382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox- and non-redox-metal-induced formation of free radicals and their role in human disease.
    Valko M; Jomova K; Rhodes CJ; Kuča K; Musílek K
    Arch Toxicol; 2016 Jan; 90(1):1-37. PubMed ID: 26343967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease.
    Maczurek A; Hager K; Kenklies M; Sharman M; Martins R; Engel J; Carlson DA; Münch G
    Adv Drug Deliv Rev; 2008; 60(13-14):1463-70. PubMed ID: 18655815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoic acid as a novel treatment for Alzheimer's disease and related dementias.
    Holmquist L; Stuchbury G; Berbaum K; Muscat S; Young S; Hager K; Engel J; Münch G
    Pharmacol Ther; 2007 Jan; 113(1):154-64. PubMed ID: 16989905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidants and prevention of chronic disease.
    Willcox JK; Ash SL; Catignani GL
    Crit Rev Food Sci Nutr; 2004; 44(4):275-95. PubMed ID: 15462130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress.
    Perluigi M; Joshi G; Sultana R; Calabrese V; De Marco C; Coccia R; Butterfield DA
    Neuroscience; 2006; 138(4):1161-70. PubMed ID: 16427207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free radicals, antioxidant defense systems, and schizophrenia.
    Wu JQ; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():200-6. PubMed ID: 23470289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialic Acid Hydroxamate: A Potential Antioxidant and Inhibitor of Metal-Induced β-Amyloid Aggregates.
    Yadav R; Murthy RV; Kikkeri R
    Chembiochem; 2015 Jul; 16(10):1448-53. PubMed ID: 25944626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in Aβ(1-42)-induced rat model of Alzheimer's disease.
    Turunc Bayrakdar E; Uyanikgil Y; Kanit L; Koylu E; Yalcin A
    Free Radic Res; 2014 Feb; 48(2):146-58. PubMed ID: 24151909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orally Bioavailable Metal Chelators and Radical Scavengers: Multifunctional Antioxidants for the Coadjutant Treatment of Neurodegenerative Diseases.
    Kawada H; Kador PF
    J Med Chem; 2015 Nov; 58(22):8796-805. PubMed ID: 26068053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abeta40, either soluble or aggregated, is a remarkably potent antioxidant in cell-free oxidative systems.
    Baruch-Suchodolsky R; Fischer B
    Biochemistry; 2009 May; 48(20):4354-70. PubMed ID: 19320465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hallmarks of protein oxidative damage in neurodegenerative diseases: focus on Alzheimer's disease.
    Polidori MC; Griffiths HR; Mariani E; Mecocci P
    Amino Acids; 2007; 32(4):553-9. PubMed ID: 17273806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metal chelation, radical scavenging and inhibition of Aβ₄₂ fibrillation by food constituents in relation to Alzheimer's disease.
    Chan S; Kantham S; Rao VM; Palanivelu MK; Pham HL; Shaw PN; McGeary RP; Ross BP
    Food Chem; 2016 May; 199():185-94. PubMed ID: 26775960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulatory effect of glutathione status and antioxidants on methylmercury-induced free radical formation in primary cultures of cerebral astrocytes.
    Shanker G; Syversen T; Aschner JL; Aschner M
    Brain Res Mol Brain Res; 2005 Jun; 137(1-2):11-22. PubMed ID: 15950756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of the suppression of free radical overproduction by antioxidants.
    Kostyuk VA; Potapovich AI
    Front Biosci (Elite Ed); 2009 Jun; 1(1):179-88. PubMed ID: 19482635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid Multifunctional Modulators Inhibit Multifaceted Aβ Toxicity and Prevent Mitochondrial Damage.
    Rajasekhar K; Mehta K; Govindaraju T
    ACS Chem Neurosci; 2018 Jun; 9(6):1432-1440. PubMed ID: 29557650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress in carcinogenesis: new synthetic compounds with dual effects upon free radicals and cancer.
    Tekiner-Gulbas B; Westwell AD; Suzen S
    Curr Med Chem; 2013; 20(36):4451-9. PubMed ID: 23834180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha-keto-beta-methyl-n-valeric acid diminishes reactive oxygen species and alters endoplasmic reticulum Ca(2+) stores.
    Huang HM; Zhang H; Ou HC; Chen HL; Gibson GE
    Free Radic Biol Med; 2004 Dec; 37(11):1779-89. PubMed ID: 15528037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.